Spots Global Cancer Trial Database for amg 479
Every month we try and update this database with for amg 479 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| QUILT-2.019: A Study of AMG 655 or AMG 479 in Combination With Gemcitabine for Treatment of Metastatic Pancreatic Cancer | NCT00630552 | Adenocarcinoma ... Metastatic Panc... Pancreatic Canc... | Placebo AMG 479 AMG 655 | 18 Years - | NantCell, Inc. | |
| QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas | NCT01231347 | Adenocarcinoma ... Advanced Solid ... Cancer Cancer of Pancr... Cancer of the P... Metastases Metastatic Canc... Metastatic Panc... Pancreas Cancer Pancreatic Canc... Bone Metastases Endocrine Cance... Oncology Oncology Patien... Solid Tumors Advanced Malign... | AMG 479 Placebo AMG 479 gemcitabine | 18 Years - | NantCell, Inc. | |
| Ganitumab in Locally Advanced Unresectable Adenocarcinoma of the Pancreas | NCT01318642 | Adenocarcinoma ... Locally Advance... Unresectable | Gemcitabine AMG 479 Placebo | 18 Years - | Amgen | |
| QUILT-2.016: Study of AMG 479 With Biologics or Chemotherapy for Subjects With Advanced Solid Tumors | NCT00974896 | Advanced Malign... Advanced Solid ... Cancer Solid Tumors Tumors | AMG 479 | 18 Years - | NantCell, Inc. | |
| QUILT-2.013: A Trial of AMG 479 or AMG 102 in Combination With Platinum-based Chemotherapy as First-Line Treatment for Extensive Stage Small Cell Lung Cancer | NCT00791154 | Lung Cancer Small Cell Lung... Solid Tumors Extensive-stage... | AMG 479 Etoposide Placebo AMG 102 Carboplatin Cisplatin | 18 Years - | NantCell, Inc. | |
| QUILT-2.016: Study of AMG 479 With Biologics or Chemotherapy for Subjects With Advanced Solid Tumors | NCT00974896 | Advanced Malign... Advanced Solid ... Cancer Solid Tumors Tumors | AMG 479 | 18 Years - | NantCell, Inc. | |
| AMG 479 in Advanced Carcinoid and Pancreatic Neuroendocrine Tumors | NCT01024387 | Neuroendocrine ... Carcinoid Tumor Pancreatic Neur... | AMG 479 | 18 Years - | Dana-Farber Cancer Institute | |
| Study of AMG 479 as Second Line Therapy in Patients With Recurrent Platinum-sensitive Ovarian Cancer | NCT00719212 | Ovarian Neoplas... | AMG 479 | 18 Years - | Translational Research in Oncology | |
| QUILT-2.018: Safety & Efficacy of FOLFIRI With AMG 479 or AMG 655 vs FOLFIRI Alone in KRAS-mutant Metastatic Colorectal Carcinoma | NCT00813605 | Metastatic Colo... | FOLFIRI AMG 655 Placebo AMG 479 | 18 Years - | NantCell, Inc. | |
| Trastuzumab in Combination With AMG 479 in HER-2 Overexpressing MBC Progressing on Trastuzumab | NCT01479179 | Breast Cancer | AMG 479 Trastuzumab | 18 Years - | M.D. Anderson Cancer Center | |
| Panitumumab Combination Study With Rilotumumab or Ganitumab in Wild-type Kirsten Rat Sarcoma Virus Oncogene Homolog (KRAS) Metastatic Colorectal Cancer (mCRC) | NCT00788957 | Colon Cancer Colorectal Canc... Gastrointestina... Metastatic Colo... Rectal Cancer | Panitumumab Ganitumab Rilotumumab Placebo | 18 Years - | Amgen | |
| A Phase Ib/II Study of the Combination of BYL719 Plus AMG 479 in Adult Patients With Selected Solid Tumors | NCT01708161 | PIK3CA Mutated ... PIK3CA Amplifie... | BYL719 AMG 479 | 18 Years - | Novartis | |
| QUILT-2.018: Safety & Efficacy of FOLFIRI With AMG 479 or AMG 655 vs FOLFIRI Alone in KRAS-mutant Metastatic Colorectal Carcinoma | NCT00813605 | Metastatic Colo... | FOLFIRI AMG 655 Placebo AMG 479 | 18 Years - | NantCell, Inc. | |
| A Trial of AMG 479, Everolimus (RAD001) and Panitumumab in Patients With Advanced Cancer - QUILT-3.007 | NCT01061788 | Advanced Solid ... | AMG 479, Everol... | 18 Years - 90 Years | Duke University | |
| A Study of MEK162 and AMG 479 in Patients With Selected Solid Tumors | NCT01562899 | Metastatic Panc... BRAF Mutated Me... | MEK162 AMG 479 | 18 Years - | Pfizer | |
| Study of Adding AMG 479 to First Line Chemotherapy in Patients With Optimally Debulked Epithelial Ovarian Cancer | NCT00718523 | Ovarian Neoplas... | AMG 479 AMG 479 Placebo | 18 Years - | Translational Research in Oncology | |
| QUILT-3.025: A Phase 2 Study of AMG 479 in Relapsed or Refractory Ewing's Family Tumor and Desmoplastic Small Round Cell Tumors | NCT00563680 | Askin's Tumors Desmoplastic Sm... Estraosseous Ew... Ewing's Family ... Ewing's Sarcoma Primitive Neuro... Sarcoma | AMG 479 | 16 Years - | NantCell, Inc. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
